Recurrent Rectal Cancer Active Not Recruiting Phase 1 Trials for Oxaliplatin (DB00526)

Also known as: Rectal cancer recurrent / Carcinoma rectum recurrent / Rectal carcinoma recurrent / Carcinoma of rectum recurrent

IndicationStatusPhase
DBCOND0028583 (Recurrent Rectal Cancer)Active Not Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02270606Phase I Study of Neoadjuvant Radiotherapy With 5-Fluorouracil for Rectal CancerTreatment